Wednesday, February 02, 2022
ADHD Medicine May Treat Symptoms of Genetic Movement Disorder in Children, University of Maryland School of Medicine Study Finds
Using a common attention deficit hyperactivity disorder (ADHD) medication appears to help manage the symptoms of a rare and currently difficult to treat genetic movement disorder primarily found in children, according to a new study from a University of Maryland School of Medicine (UMSOM) researcher Andrea Meredith, PhD, and her collaborators.
Tuesday, February 01, 2022
Study: Losing Excess Weight in Adulthood Reduces Risk of Developing Polyps that can Lead to Colorectal Cancer
Weight loss for adults, particularly those who are overweight or obese, may reduce their risk of developing a type of polyp that can lead to colorectal cancer, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM). Findings were published today in the journal JNCI Cancer Spectrum.
Monday, January 31, 2022
New Technique Consistently Works to Open Blood-Brain Barrier, Paving Way for Pre-Clinical Studies of Neurologic Drugs
University of Maryland School of Medicine researchers developed a technique in laboratory animals to consistently and reproducibly open the blood-brain barrier. This barrier serves as a barricade securing the brain from the external world blocking out certain environmental toxins, but also prevents drug therapies from reaching their intended targets. The new technique is based on a routine procedure for removing clots from the brain’s arteries in patients. This advancement was conducted by Piotr Walczak, MD, PhD, Professor of Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine, and Miroslaw Janowski, MD, PhD, Associate Professor of Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine.
Thursday, January 27, 2022
16th Annual Medical Student Auction Supports Fight Against Food Insecurity
In keeping with tradition since 2006, the University of Maryland School of Medicine (UMSOM) Class of 2024 Student Government has organized this year’s Annual Second-Year Medical Student Auction. A portion of the proceeds will be donated to Bmore Community Food, an organization committed to serving the vulnerable and marginalized population in Baltimore City who are experiencing food insecurity. The remaining funds will support the Class of 2024 medical student activities.
Thursday, January 27, 2022
Microbiome of Mother’s Vagina May Affect Infant Mortality Risk and Baby’s Development
A new study in mice from University of Maryland School of Medicine researchers showed that an unhealthy vaginal microbiome in pregnant mothers in combination with an unhealthy diet contributed to increased pup deaths and altered development in the surviving babies.
Wednesday, January 26, 2022
Trial Co-led by University of Maryland School of Medicine Scientist Confirms Safety of “Mix-and-Match” COVID-19 Vaccine Booster Dosing
A University of Maryland School of Medicine (UMSOM), Center for Vaccine Development and Global Health (CVD), expert is co-leading an ongoing study that was pivotal in recommending adults and teens receive booster COVID-19 shots of their choosing starting in fall 2021. The preliminary clinical trial results, reported today in The New England Journal of Medicine, found that is safe and effective to receive boosters that are the same or a different one from the person’s primary vaccine(s).
Monday, January 24, 2022
UM School of Medicine Surgery Professor Jonathan Bromberg, MD, PhD, Receives Prestigious NIH Award for Research on Immune System Regulation
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA announced today that Jonathan Bromberg, MD, PhD, Professor of Surgery and Vice Chair for Research in the Department of Surgery, has received a prestigious aw ard from the National Institutes of Health (NIH) for his research into how the immune system regulates itself in the area of transplantation. The $2.3 million grant will enable him to learn more about how the immune system’s gatekeepers, called regulatory T cells, work to suppress the body’s immune response.
Wednesday, January 19, 2022
World-Renowned University of Maryland School of Medicine Trauma Surgeon and Physician-Scientist Celebrates 25th Anniversary
As the Honorable Francis X. Kelly Distinguished Professor of Trauma Surgery and Director of the Program in Trauma at the University of Maryland School of Medicine (UMSOM) and Physician-in-Chief of the R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center (UMMC), Thomas M. Scalea, MD, FACS, MCCM, has pioneered advances to trauma care for patients in the United States and around the world. He has cared for tens of thousands of Marylanders critically injured in motor vehicle collisions, falls and violent attacks, traveled to China and Haiti to render assistance to earthquake victims, helped train thousands of U.S. Air Force personnel and worked alongside military physicians in war-torn Afghanistan. He has steered Maryland’s highest-level trauma center through two years of the COVID-19 pandemic.
Monday, January 10, 2022
University of Maryland School of Medicine Faculty Scientists and Clinicians Perform Historic First Successful Transplant of Porcine Heart into Adult Human with End-Stage Heart Disease
In a first-of-its-kind surgery, a 57-year-old patient with terminal heart disease received a successful transplant of a genetically-modified pig heart and is still doing well three days later. It was the only currently available option for the patient. The historic surgery was conducted by University of Maryland School of Medicine (UMSOM) faculty at the University of Maryland Medical Center (UMMC), together known as the University of Maryland Medicine.
Thursday, December 16, 2021
Novavax COVID-19 Vaccine Found to be Safe and Effective in Phase 3 Trial Conducted by UM School of Medicine Researchers
An investigational COVID-19 vaccine made by Novavax was found to be 90 percent effective at preventing COVID-19 illness, according to results from a Phase 3 clinical trial published today in the New England Journal of Medicine. The University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health served as one of the trial sites, and Karen Kotloff, MD, Professor of Pediatrics at UMSOM, served as Co-Chair for the trial protocol.